机译:Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature
Metabolism and Diabetes Unit, ASL TO5, Regione Piemonte, Chieri, Italy;
Incretins or DPP-4 inhibitors or GLP-1 receptor agonists; Safety; Efficacy; Renal impairment Hepatic impairment;